USFDA approves Unichem’s Atenolol and Chlorthalidone Tablets

Last Updated on December 31, 2023 by The Health Master

Unichem Laboratories has received ANDA approval for its Atenolol and Chlorthalidone Tablets, USP 50 mg/25 mg and 100 mg/25 mg from the United States Food and Drug Administration (USFDA) to market a generic version of TENORETIC (atenolol and chlorthalidone) Tablets of Alvogen Malta Operations.

Atenolol and Chlorthalidone Tablets are indicated for the treatment of hypertension, to lower blood pressure.

The product will be commercialized from Unichem’s Ghaziabad Plant.

• Yoga may be beneficial in Rheumatoid Arthritis: AIIMS study
• HM Calls for Transparent CDSCO to Ensure Quality
• USFDA approval granted for the drug used for Colon Cleansing
• USFDA issues positive EIR to Lupin Limited at Gujarat
• Drug Rules to include excipient details in drug labels
• USFDA approval granted for the drug for the treatment of Migraine

The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram..